Caber half-life
Cabergoline is a prescription dopamine agonist with a very long elimination half-life of roughly 63 to 69 hours, so its blood level falls by half only about every 3 days. That slow clearance is why it is taken just once or twice a week instead of daily, and why repeated doses accumulate to a steady level over roughly 4 weeks. Its metabolites are not active, so the long duration reflects the parent drug itself.
What a half-life actually means
A half-life is the time it takes for half of what is in your blood to be gone. It does not mean the compound is finished at that point. Half goes, then half of what is left goes, and so on.
That is why the last traces take so much longer to disappear than the first. Most references treat something as effectively cleared after about five half-lives, which for Caber is roughly 13.8 days.
How Caber clears
| Half-lives | Time since dose | Roughly left |
|---|---|---|
| 1 | 2.8 days | 50% |
| 2 | 5.5 days | 25% |
| 3 | 8.2 days | 12.5% |
| 4 | 11 days | 6.25% |
| 5 | 13.8 days | 3.125% |
These are round numbers from a single half-life figure. Real clearance shifts with dose, body composition, liver and kidney function, and what else you are taking. Treat it as a shape, not a schedule.
Why the timing matters
A short half-life means levels swing between doses, so timing and frequency do most of the work. A long half-life means levels build for days or weeks before they settle, so a change you make today might not show up for a while, and stopping does not clear things straight away.
Caber sits at about 2.8 days, so it behaves like the medium end of that range.
See your own levels, not a table
NextDose models your actual blood level from the doses you log, then calibrates the curve to your bloodwork. Built on 30,000+ research papers, clinical trials and FDA records.
Get NextDose.AIResearch mentioning Caber
Indexed records from PubMed and ClinicalTrials.gov that reference Caber. These are here so you can read the primary material yourself. They are not the source of the half-life figure above.